NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Healsun Biopharm

Healsun Biopharm

Private
HangzhouHealthcare & Life Scienceshttps://hs-biopharm.com/

Last Round

Series C

Nov 19, 2023

Total Funding Raised

$83.99M

Company Overview

Healsun Biopharm is a biotechnology company that provides one-stop CDMO services for antibody, fusion protein, and antibody-drug conjugate (ADC) development, ranging from protein engineering and CMC process development to commercial production.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

active pharmaceutical ingredientsAPIcontract development and manufacturing organizationCDMOpharmaceutical intermediatescustom synthesiscontract research organizationCROcell line developmentantibody drug conjugateADCCMC process developmentGMP manufacturingdrug manufacturingpharma supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Healsun Biopharm Comparables

Compare Healsun Biopharm with similar companies based on industry and business-model similarity.

Healsun Biopharm comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Asymchem
74%
Intellective Biologics (Suzhou) Co., Ltd.
74%
WuXi AppTec
73%

Healsun Biopharm Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CNov 19, 2023
Series BOct 7, 2023
Series BAug 18, 2022
Series AApr 12, 2021
Series AAug 9, 2018

Healsun Biopharm Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 18, 2022

    $37M round with participation from Haitong Capital.

Healsun Biopharm Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Healsun Biopharm Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Healsun Biopharm's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range5
Year Founded2015
Last FundingNov 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.